Chan et al. further found that the ROMA showed an improved specificity and PPV (34.69% vs. 16.8%, respectively) but a similar specificity and PPV when compared with CA125 for the prediction of ovarian cancer in Asian women with a pelvic mass. Here, MUC16 is linked to ovarian cancer.